These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Dopamine D-2 receptors inhibit D-1 stimulated cyclic AMP accumulation in striatum but not limbic forebrain. Kelly E, Nahorski SR. Naunyn Schmiedebergs Arch Pharmacol; 1987 May; 335(5):508-12. PubMed ID: 2441268 [Abstract] [Full Text] [Related]
8. A mechanism underlying dopamine D1 and D2 receptor-mediated inhibition of dopaminergic neurones in the ventral tegmental area in vitro. Momiyama T, Todo N, Sasa M. Br J Pharmacol; 1993 Aug; 109(4):933-40. PubMed ID: 8104652 [Abstract] [Full Text] [Related]
9. The action of dopamine and vascular dopamine (DA1) receptor agonists on human isolated subcutaneous and omental small arteries. Hughes AD, Sever PS. Br J Pharmacol; 1989 Jul; 97(3):950-6. PubMed ID: 2474354 [Abstract] [Full Text] [Related]
10. Excitatory neuronal responses to dopamine in the cerebral cortex: involvement of D2 but not D1 dopamine receptors. Bradshaw CM, Sheridan RD, Szabadi E. Br J Pharmacol; 1985 Oct; 86(2):483-90. PubMed ID: 2932196 [Abstract] [Full Text] [Related]
11. Effects of dopamine agonists on excitatory inputs to nucleus accumbens neurons from the amygdala: modulatory actions of cholecystokinin. Liang RZ, Wu M, Yim CC, Mogenson GJ. Brain Res; 1991 Jul 19; 554(1-2):85-94. PubMed ID: 1681991 [Abstract] [Full Text] [Related]
12. The regulation of dopamine release from nigrostriatal neurons in conscious rats: the role of somatodendritic autoreceptors. Santiago M, Westerink BH. Eur J Pharmacol; 1991 Oct 29; 204(1):79-85. PubMed ID: 1687125 [Abstract] [Full Text] [Related]
13. Acetylcholine release in rat nucleus accumbens is regulated through dopamine D2-receptors. Wedzony K, Limberger N, Späth L, Wichmann T, Starke K. Naunyn Schmiedebergs Arch Pharmacol; 1988 Sep 29; 338(3):250-5. PubMed ID: 3264055 [Abstract] [Full Text] [Related]
14. Effects of locally applied D-1 and D-2 receptor agonists and antagonists studied with brain dialysis. Imperato A, Di Chiara G. Eur J Pharmacol; 1988 Nov 08; 156(3):385-93. PubMed ID: 2905668 [Abstract] [Full Text] [Related]
15. Yawning produced by dopamine agonists in rhesus monkeys. Code RA, Tang AH. Eur J Pharmacol; 1991 Aug 29; 201(2-3):235-8. PubMed ID: 1686760 [Abstract] [Full Text] [Related]
16. Dopamine D-1 and D-2 receptor agonists and antagonists and neuropeptide-induced excessive grooming. Van Wimersma Greidanus TB, Maigret C, Torn M, Ronner E, Van der Kracht S, Van der Wee NJ, Versteeg DH. Eur J Pharmacol; 1989 Dec 07; 173(2-3):227-31. PubMed ID: 2576230 [Abstract] [Full Text] [Related]
17. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses. Weick BG, Walters JR. Brain Res; 1987 Mar 10; 405(2):234-46. PubMed ID: 2952219 [Abstract] [Full Text] [Related]
18. Influence of fenoldopam and quinpirole in the guinea-pig stomach. Guenaneche F, Schuurkes JA, Lefebvre RA. J Auton Pharmacol; 1991 Aug 10; 11(4):221-35. PubMed ID: 1682324 [Abstract] [Full Text] [Related]
19. Interactions between dopamine D1 and D2 receptors in the model of thyrotropin-releasing hormone (TRH)-induced behaviour in rabbits. Popoli P, Caporali MG, Scotti de Carolis A. Eur J Pharmacol; 1991 Aug 16; 201(1):11-6. PubMed ID: 1686587 [Abstract] [Full Text] [Related]
20. Effect of dopamine D-1 and D-2 receptor selective drugs on dopamine release and metabolism in rat striatum in vivo. Zetterström T, Sharp T, Ungerstedt U. Naunyn Schmiedebergs Arch Pharmacol; 1986 Oct 16; 334(2):117-24. PubMed ID: 2946964 [Abstract] [Full Text] [Related] Page: [Next] [New Search]